Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
ESRX Express Scripts Holding Company daily Stock Chart
Express Scripts Holding Company
IndexS&P 500 P/E27.12 EPS (ttm)3.05 Insider Own0.23% Shs Outstand675.73M Perf Week0.71%
Market Cap55.90B Forward P/E13.65 EPS next Y6.06 Insider Trans-6.21% Shs Float674.04M Perf Month-1.41%
Income2.21B PEG2.13 EPS next Q1.44 Inst Own98.20% Short Float9.14% Perf Quarter-9.19%
Sales102.44B P/S0.55 EPS this Y14.30% Inst Trans-0.03% Short Ratio14.01 Perf Half Y-6.11%
Book/sh23.43 P/B3.53 EPS next Y10.12% ROA4.20% Target Price99.30 Perf Year17.43%
Cash/sh1.07 P/C77.53 EPS next 5Y12.71% ROE11.50% 52W Range68.06 - 94.61 Perf YTD-2.30%
Dividend- P/FCF13.29 EPS past 5Y11.20% ROI7.60% 52W High-12.57% Beta1.35
Dividend %- Quick Ratio0.50 Sales past 5Y32.50% Gross Margin8.30% 52W Low21.54% ATR1.75
Employees29500 Current Ratio0.60 Sales Q/Q1.40% Oper. Margin4.60% RSI (14)47.06 Volatility2.15% 2.06%
OptionableYes Debt/Eq1.06 EPS Q/Q31.30% Profit Margin2.20% Rel Volume0.66 Prev Close82.71
ShortableYes LT Debt/Eq0.92 EarningsOct 27 AMC Payout0.00% Avg Volume4.40M Price82.72
Recom2.30 SMA200.09% SMA50-2.68% SMA200-3.81% Volume2,921,030 Change0.01%
Oct-05-15Reiterated Leerink Partners Outperform $105 → $95
Jul-30-15Reiterated RBC Capital Mkts Outperform $87 → $96
Jul-16-15Initiated Mizuho Buy $98 → $101
Jun-18-15Initiated Oppenheimer Perform
Jun-01-15Downgrade Raymond James Outperform → Mkt Perform
May-20-15Initiated Robert W. Baird Neutral $94
Mar-10-15Reiterated RBC Capital Mkts Outperform $82 → $87
Feb-24-15Reiterated Mizuho Buy $94 → $98
Feb-24-15Reiterated Maxim Group Buy $90 → $109
Jan-28-15Downgrade FBR Capital Outperform → Mkt Perform
Jan-08-15Reiterated Mizuho Buy $82 → $94
Dec-16-14Reiterated Oppenheimer Outperform $82 → $88
Dec-15-14Reiterated UBS Buy $82 → $96
Dec-04-14Reiterated Deutsche Bank Hold $76 → $88
Dec-03-14Reiterated Barclays Overweight $83 → $94
Oct-30-14Reiterated RBC Capital Mkts Outperform $73 → $82
Jul-30-14Reiterated FBR Capital Outperform $79 → $74
Jul-28-14Reiterated UBS Buy $90 → $82
May-01-14Reiterated Maxim Group Buy $92 → $90
Apr-30-14Reiterated Mizuho Buy $86 → $82
Oct-09-15 04:00PM  Express Scripts Miller: Good economics in plan to limit drug costs at
Oct-07-15 04:48PM  Express Scripts Includes Praluent and Repatha in Formulary
12:02PM  Cholesterol Busters Will Be Cheaper but Remain Top Sellers at Motley Fool
11:35AM  Regeneron, Amgen Up As PCSK9s Gain Key Coverage at Investor's Business Daily
10:49AM  Express Scripts looks to limit drug price increases at CNBC
08:35AM  Express Scripts to cover new $14,000 drugs at
12:40AM  Express Scripts to Cover Both New Cholesterol Drugs at The Wall Street Journal
Oct-06-15 11:00PM  Prescription firm agrees to cover pricey new cholesterol drugs -- for some at Los Angeles Times
10:09PM  Express Scripts to Cover Both New Cholesterol Drugs at The Wall Street Journal
08:32PM  Express Scripts to cover pricey new cholesterol treatments
08:00PM  Amgen, Sanofi Cholesterol Drugs Covered by Express Scripts at Bloomberg
05:25PM  Express Scripts agrees deal for heart drugs at Financial Times
05:10PM  Express Scripts Says It Will Save America Money On New Cholesterol Drugs, But Its Math Doesn't Check Out at Forbes
05:07PM  Cholesterol drug coverage won't bust budgets
05:00PM  How Express Scripts plans to cover a $14,000 drug at CNBC
05:00PM  Express Scripts Includes Innovative Cholesterol-Lowering Drugs on National Preferred Formulary PR Newswire
04:59PM  AmerisourceBergen Corporation -- Moody's affirms AmerisourceBergen's Baa2 ratings on news of PharMEDium deal; outlook changed to negative at Moody's
04:30PM  Valeant Shares Down 37% since August; More Pain Ahead?
Oct-05-15 01:30PM  These mega-caps are offering heavy upsides: Pros
Oct-02-15 12:32PM  Morgan Stanley Says These 9 Health Care Stocks Are Best-Positioned, Despite Rising Drug Prices at TheStreet
Sep-30-15 05:39PM  New cholesterol drugs won't be budget busters -Express Scripts Reuters
04:10PM  Express Scripts says Praluent, Repatha will not be "budget busters" Reuters
09:30AM  The Zacks Analyst Blog Highlights: Express Scripts, AbbVie, Amgen, Anika Therapeutics and PDL BioPharma
Sep-28-15 08:16AM  Not all buybacks are equal: Pro
Sep-25-15 01:33PM  PKWs BuyBack Achiever Performances in 2015
12:04PM  Companies Return Money to Shareholders at Record Rate in Q2
Sep-23-15 04:39PM  Here are the 5 drug classes with the biggest price gains at Fortune
08:21AM  What Stocks Benefit From Hillary Clinton's Drug Pricing Plan? at Motley Fool
Sep-22-15 01:46PM  Your money or your life?
11:55AM  How Key Analyst Sees PBMs Responding to Hillarys Tweet at 24/7 Wall St.
Sep-17-15 10:57AM  The cost of not taking meds as prescribed: $330 billion at MarketWatch
Sep-16-15 09:02AM  The best prescription for double-digit returns at CNBC
Sep-15-15 10:56AM  JPMorgan's 6 Health Care Stocks to Buy for the Rest of 2015 at TheStreet
Sep-11-15 04:02PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of
07:30AM  Express Scripts Names a New CEO at Investopedia
Sep-10-15 05:21PM  Express Scripts Names Eric Slusser CFO at The Wall Street Journal
04:45PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
04:30PM  Express Scripts Names Eric Slusser Chief Financial Officer PR Newswire
03:24PM  Express Scripts' CEO Swap: What Wall Street Thinks
09:58AM  Express Scripts (ESRX) Stock Climbs Following CEO Announcement at TheStreet
09:11AM  Ahead of the Bell: Express Scripts details leadership change
07:51AM  Early movers: LULU, STX, COH, PFE, MDLZ & more at CNBC
Sep-09-15 05:52PM  Express Scripts CEO George Paz to retire in May
05:26PM  Express Scripts CEO Plans to Retire at The Wall Street Journal
05:25PM  Paz to step down as Express Scripts CEO at
05:23PM  Express Scripts says George Paz will step down as CEO in May
04:54PM  Will Express Scripts (ESRX) Stock Be Helped by New CEO? at TheStreet
04:51PM  Express Scripts CEO George Paz to retire
04:48PM  Express Scripts names Tim Wentworth CEO, effective May 2016 at MarketWatch
04:43PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
04:30PM  Express Scripts Names Tim Wentworth Chief Executive Officer, Effective May 2016; George Paz to Retire and Remain as Chairman PR Newswire
02:33PM  Cowen Upgrades Walgreens: Here's Why
Sep-08-15 04:31PM  Health Care Sector Still Riding Obamacare Momentum at Forbes
Sep-04-15 04:03PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers
Aug-28-15 12:45PM  Halftime Portfolio: Jon buys Seadrill
10:35AM  Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S.
06:00AM  Amgen approved for pricey new drug
Aug-27-15 10:07PM  The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles at Forbes
06:43PM  FDA approves Amgen's cholesterol-lowering drug Repatha Reuters
Aug-26-15 08:48AM  Near-term stock swaps
Aug-24-15 05:54PM  LabCorp Reaching Past Doctor's Office To The Patient at Investor's Business Daily
Aug-20-15 05:54PM  Dividend cuts for big oil?
05:42PM  Cholesterol war heats up
Aug-18-15 07:32PM  Jeremy Grantham Reduces More Than 250 Stakes in Second Quarter
06:51PM  Why Target will be different than Wal-Mart: Analyst at CNBC
10:15AM  Target brings in Cathy Smith as CFO at
Aug-17-15 05:09PM  Target Goes Outside for New CFO After Internal Promotion at The Wall Street Journal
03:02PM  Think Amazon's Bad? Here are 6 Companies with Worse Culture at TheStreet
09:01AM  Target promotes CFO Mulligan to COO
08:46AM  Executive changes at the top at Target
Aug-16-15 01:18PM  3 Charts That Show Healthcare Stocks Should Stay Hot for Years to Come at Motley Fool
Aug-14-15 07:08AM  Lilly CEO talks drug pricing pressure
Aug-13-15 11:34AM  Gilead Sciences: Why Hepatitis-C Sales Could Fall Short at
07:08AM  The 5 Least Inspiring CEOs in America at Motley Fool
Aug-12-15 10:40AM  The Next Great Dividend Stocks of the S&P 500 at Kiplinger
Aug-11-15 09:07AM  CVS Reports a Solid Quarter and Outlook in Pharmacy Services
04:16AM  Sellers target Express Scripts
Aug-10-15 05:05PM  CVS Healths Upbeat Outlook for 2Q15 and 2015
02:40PM  CVS, Express Scripts Pick Drugs to Restrict; Did Gilead's Sovalidi Make the Cut? at
12:39PM  Pharmacy benefit manager CVS urges rewrite for U.S. heart guidelines
10:11AM  Earnings Analysis: CVS Healths Performance in 2Q15
09:30AM  Zacks Investment Ideas feature highlights: INC Research, AMN Healthcare Services, Charles River Associates, Envision Healthcare and Express Scripts - Press Releases
Aug-06-15 11:53PM  Drug-Plan Managers Wield Potent Weapon at The Wall Street Journal
07:54PM  Drug-Plan Managers Wield 'Potent Weapon' at The Wall Street Journal
07:18AM  What Does the Social Media Crowd Think About Express Scripts (ESRX) Stock? - Tale of the Tape
Aug-05-15 05:37PM  CVS strips Viagra, other top drugs, from insurance coverage
Aug-04-15 12:06PM  Express Scripts Holding Co. Earnings Q2*, 2015
10:04AM  No More Viagra: CVS Drops Coverage of Erectile Dysfunction Drug at Bloomberg
09:07AM  Drivers That Impact CVSs Pharmacy Services Segment
Aug-01-15 01:04PM  EXPRESS SCRIPTS HOLDING CO. Financials
Jul-31-15 04:24PM  Express Scripts excludes 20 more drugs from 2016 coverage Reuters
Jul-29-15 11:12PM  How Express Scripts Makes Money at Investopedia
06:26PM  Express Scripts says costly new cholesterol drugs could 'wreak havoc' Reuters
05:40PM  DoD awards medical records contract to Cerner, Leidos & A...
04:30PM  Edited Transcript of ESRX earnings conference call or presentation 29-Jul-15 12:30pm GMT
03:42PM  Express Scripts (ESRX) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
12:24PM  Dow adds 100 points as Street awaits Fed statement; earnings eyed at CNBC
11:21AM  Express Scripts Holding Company Posts Solid Q2 Earnings at Motley Fool
11:15AM  Express Scripts says costly new cholesterol drugs could wreak havoc Reuters
09:35AM  Express Scripts (ESRX) Tops Q2 Earnings, Ups 2015 View - Analyst Blog
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company's PBM segment's services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services for pharmaceutical manufacturers to collect scientific evidence to guide the use of medicines, as well as case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wimberly GarySr. VP & Ch. Information Off.Jun 09Sale87.141,644143,26020,885Jun 11 03:29 PM
Wimberly GarySr. VP & Ch. Information Off.Jun 01Option Exercise57.4946,0692,648,45868,598Jun 03 04:01 PM
Wimberly GarySr. VP & Ch. Information Off.Jun 01Sale86.1546,0693,968,84422,529Jun 03 04:01 PM
STERNBERG SEYMOURDirectorMay 27Option Exercise52.536,870360,88111,267May 29 04:02 PM
STERNBERG SEYMOURDirectorMay 27Sale90.236,870619,8594,397May 29 04:02 PM
MYERS WOODROW A JRDirectorMay 08Option Exercise54.0314,342774,92926,720May 12 04:14 PM
MYERS WOODROW A JRDirectorMay 08Sale85.3214,3421,223,64512,378May 12 04:14 PM
BENANAV GARY GDirectorMay 04Option Exercise30.8313,128404,73656,139May 06 04:01 PM
BENANAV GARY GDirectorMay 04Sale87.3910,000873,85046,139May 06 04:01 PM
Norton David ASVP, Specialty & Supply ChainMay 01Option Exercise49.507,000346,46523,280May 05 04:07 PM
Wade Sara ESr. VP, Ch. Human Res. Off.May 01Sale86.5312,0001,038,30028,599May 05 04:09 PM
Norton David ASVP, Specialty & Supply ChainMay 01Sale86.5312,0291,040,80911,251May 05 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 02Sale84.392,674225,6598,291Mar 03 04:15 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 25Sale87.315,864511,98610,965Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Option Exercise47.6121,7391,034,99438,568Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Sale87.6221,7391,904,77016,829Feb 26 04:03 PM
Ebling Keith J.Exec. VP and General CounselDec 02Sale84.2510,000842,5000Dec 03 04:04 PM
Miller Steven BSr. VP & Chief Med. OfficerDec 01Sale83.574,896409,14416,521Dec 03 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Option Exercise47.6110,800514,18830,657Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Sale82.9610,800895,94619,857Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Option Exercise47.6110,874517,71130,731Nov 25 04:38 PM
MAC MAHON THOMAS PDirectorNov 21Option Exercise35.8512,694455,01654,066Nov 25 04:40 PM
MAC MAHON THOMAS PDirectorNov 21Sale80.9312,6941,027,35141,372Nov 25 04:40 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Sale81.5010,874886,23119,857Nov 25 04:38 PM
PARKER JOHN ODirectorNov 17Option Exercise33.3025,822859,75365,503Nov 18 05:04 PM
PARKER JOHN ODirectorNov 17Sale78.7525,8222,033,43139,681Nov 18 05:04 PM
Breen Maura CDirectorNov 07Option Exercise30.8313,128404,73630,438Nov 10 04:16 PM
Breen Maura CDirectorNov 07Sale77.8013,1281,021,34517,310Nov 10 04:16 PM